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Matrix metalloproteinases (MMPs) are zinc-dependent endopeptidases that play a role in varied forms of developmental and
postnatal neuroplasticity. MMP substrates include protease-activated receptor-1 (PAR-1), a G-protein coupled receptor expressed
in hippocampus. We examined proliferation and differentiation of adult neural progenitor cells (aNPCs) from hippocampi of mice
that overexpress the potent PAR-1 agonistMMP-1.We found that, as compared to aNPCs from littermate controls,MMP-1 tg aNPCs
display enhanced proliferation. Under differentiating conditions, these cells give rise to a higher percentage of MAP-2+ neurons
and a reduced number of oligodendrocyte precursors, and no change in the number of astrocytes. The fact that these results are
MMP and PAR-1 dependent is supported by studies with distinct antagonists. Moreover, JSH-23, an inhibitor of NF-𝜅B p65 nuclear
translocation, counteracted both the proliferation and differentiation changes seen in MMP-1 tg-derived NPCs. In complementary
studies, we found that the percentage of Sox2+ undifferentiated progenitor cells is increased in hippocampi of MMP-1 tg animals,
compared to wt mice. Together, these results add to a growing body of data suggesting that MMPs are effectors of hippocampal
neuroplasticity in the adult CNS and that the MMP-1/PAR-1 axis may play a role in neurogenesis following physiological and/or
pathological stimuli.
1. Introduction
Newly born neurons that are generated in the dentate gyrus
(DG) of the adult hippocampus are increasingly appreciated
as potential effectors of cognitive flexibility, pattern separa-
tion, and spatially precise search strategies [1–3]. Dysregu-
lated adult hippocampal neurogenesis (AHN) is a correlate
of varied physiological and pathological states, and may
contribute to and/or result from the same. While adult
neurogenesis can be modulated by numerous stimuli, several
conditions characterized by an increase in progenitor cell
proliferation are coincidently associated with an increase in
the level and activity of secreted enzymes belonging to the
matrix metalloproteinase (MMP) family [4–6]. Prior studies
have also implicated MMP activity in the proliferation of
varied cell types including neural progenitors [7], but the
overall role of specific MMPs in aNPC proliferation and the
mechanism(s) or substrates important to MMP-dependent
effects are not particularly well understood.
Potential protease substrates that are highly expressed
within the adult hippocampus include synaptic cell adhesion
molecules and protease-activated receptor-1 (PAR-1), aGPCR
activated by cleavage of N-terminal sequence which in
turn exposes a tethered peptide ligand [8–10]. PAR-1 is of
particular interest to neurogenesis since it is expressed in
the DG and found on both neurons and glial cells [8, 11].
Moreover, its signaling has been linked to increases in the
function of NMDARs thought to play a role in neurogenesis
as well as to increased release of soluble factors that enhance
progenitor cell proliferation [8, 12, 13].
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PAR-1 activators include thrombin and APC, two blood-
derived proteases that may enter the CNS in response to
blood brain barrier damage as well as a small subset ofMMPs
(MMP-1 and MMP-13) [9, 14, 15]. MMP-1 in particular is
equipotent to thrombin in its ability to stimulate receptor
cleavage and PAR-1 dependent intracellular signaling [14].
Of note, however, is the fact that MMP-1 cleavage of PAR-
1 generates a relatively unique tethered peptide ligand since
cleavage occurs as a site that is two amino acids N-terminal
to the thrombin cleavage site [15].
MMP-1 has the potential to be an important PAR-1
agonist in the absence of blood brain barrier damage. It is
expressed by astrocytes [16], and while basal expression is
typically low, levels ofMMP-1may be increased in association
with physiological and pathological stimuli that are linked
to neurogenesis [17–19]. MMP-1 dependent activation of
PAR-1 has, however, not been well explored with respect
to its function in central nervous system physiology or
neurogenesis in particular.
Quiescent neural stem/progenitor cells, thought to gen-
erate neurons that will ultimately mature, express markers
including GFAP [20]. In the present study, we therefore
take advantage of a unique mouse model in which human
MMP-1 is expressed under the control of a GFAP promoter
to examine the MMP-1/PAR-1 axis in adult hippocampal
neurogenesis. Human MMP-1 is an orthologue of the much
later identified murine MMP-1a [21], and, importantly, it
activates murine PAR-1 [22]. We show that the MMP-1/PAR-
1 axis can increase both progenitor cell proliferation and
neuronal fate specification and we suggest that future studies
are warranted to determine if this axis is important to pro-
genitor cell plasticity in physiological settings such as exercise
and environmental enrichment as well as in pathological
conditions.
2. Materials and Methods
2.1. Animals. Adultmale (3-4-month-old)wild typeC57/BL6
or heterozygous littermate MMP-1 tg mice on a C57/BL6
background were used in the present study. The MMP-1 tg
animals were prepared at the Johns Hopkins University via
pronuclear injection of a glial fibrillary acid protein- (GFAP-)
MMP-1 construct.This construct encodes humanMMP-1, an
orthologue of the much later identified mouse MMP-1a [21].
Importantly, human MMP-1 cleaves murine PAR-1 [22]. We
obtained the MMP-1 construct from Dr. Jeanine D’Armiento
who has used it to overexpress MMP-1 in mouse’s heart and
lung [23, 24]. The generation of the combined GFAP-MMP-
1 construct was carried out using a GFAP promoter from
Dr. Michael Brenner [25]. All experimental procedures were
performed with approval of the Johns Hopkins University
andGeorgetownUniversityAnimal Care andUseCommittee
guidelines.
2.2. Isolation and Culture of Adult Neural Progenitor Cells
(aNPCs) from Murine Hippocampus. For each aNPC prep-
aration, three adult (3-4-month-old) male mice were hu-
manely euthanized. The brains were extracted and hippo-
campi were isolated under a dissecting microscope using fine
surgical instruments and collected in ice-cold PIPES buffer
pH 7.4 containing 20mM PIPES, 25mM glucose, 0.5M KCl,
0.12M NaCl (Sigma, St. Louis, MO), and 100U/100 𝜇g/mL
Penicillin/Streptomycin solution (Invitrogen, Carlsbad, CA).
After centrifugation (110×g × 5min), tissue was digested for
40 minutes at 37∘C using the Papain Dissociation System
(Worthington DBA, Lakewood, NJ). The cell suspension was
placed into 25 cm2 Falcon cell-culture flasks (Thermo Fisher
Scientific, Rockville, MD) and cultured in growth medium
[Neurobasal-A medium containing B27 supplement, 2mM
L-glutamine (Invitrogen), 10 ng/mL human basic fibrob-
last growth factor (bFGF-2, PeproTech, Rocky Hill, NJ),
20 ng/mL human epidermal growth factor (EGF, Sigma),
4 𝜇g/mL heparin sodium salt (Sigma), and 100U/100𝜇g/mL
Penicillin/Streptomycin]. Primary (Passage 1, P1) neuro-
spheres were passaged after 7–9 days in vitro (DIV), whereas
subsequent passages were prepared every 5 DIV. At each
passage, cells were plated in a T25 flask at a density of
12,000 cells/cm2 in growth medium. P3–P10 neurospheres
were utilized for experiments.
2.3. aNPCDifferentiation and Proliferation. For evaluation of
cell proliferation, dissociated aNPCswere plated onto Lumin-
NUNC F96 MicroWell plates (Thermo Fisher Scientific), at a
density of 4,000 cells per well, in growth medium in presence
of 1 𝜇M BMS-200261, 8 𝜇M MMP inhibitor II, 3𝜇M JSH-23
(Calbiochem,MerckKGaA,Darmstadt, Germany), or vehicle
for 0 to 72 h, as indicated. Proliferation rates were determined
by using the CellTiter-Glo Luminescent Cell Viability Assay
(Promega, Madison, WI), according to the manufacturer’s
instructions. All experiments were performed in triplicate,
and data (expressed as counts per second) represent mean ±
standard deviation (SD), as indicated.
For differentiation experiments, we used a previously
described protocol [26]. Briefly, neurospheres were disso-
ciated and plated onto laminin-coated chamber slides in
Neurobasal-A medium with B27 supplement and 2mM
L-glutamine. At plating, NPCs were treated with vehicle,
1 𝜇M of the PAR-1 antagonist BMS-200261 trifluoroacetate
(Sigma), or 3 𝜇M JSH-23 (Calbiochem). After 24 h, cells
were washed in PBS and fixed with ice-cold 4% PFA for
20min at RT for subsequent immunofluorescence analysis.
In each experiment, 5 fields/well (corresponding to 100–
150 cells/well) were evaluated. All experiments were run in
triplicate, and experiments were repeated at least three times.
Data represent the mean value ± SD as noted. In parallel, the
survival rate in culture was evaluated in each fixed culture as
previously described [26].
2.4. Immunocytochemical Analysis. After fixation, neuro-
sphere-derived differentiated cells were washed three times
in PBS and permeabilized in PBS containing 0.48% (vol/vol)
Triton X-100 (Sigma) for 5min at RT. The primary anti-
bodies against MAP-2 (rabbit polyclonal, 1 : 600, Chemicon,
Temecula, CA), GFAP (mouse monoclonal, 1 : 600, Mil-
lipore, Billerica, MA), or NG2 (rabbit polyclonal, 1 : 500,
Abcam, Cambridge, MA) were incubated for 150min at
RT in an antibody solution containing 16% (vol/vol) goat
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serum. Secondary antibodies were as follows: Alexa Fluor
488 conjugated goat anti-rabbit antibody(1 : 1600, Invitrogen)
and Alexa Fluor 488 conjugated goat anti-mouse antibody
(1 : 1600, Invitrogen). Nuclei were counterstained with DAPI
(1 : 10000, Sigma). Fluorescent Mounting Medium (Electron
Microscopy Sciences, Hatfield, PA) was applied to slides as
antifading agent prior to addition of coverslips.
2.5. Protein Isolation and Western Blot Analysis. For protein
isolation, aNPCwere lysed in 3x vol/vol of ice-cold hypotonic
RIPA buffer [50mM Tris-HCl pH 7.5, 150mMNaCl, 0.5mM
EDTA pH 8, 1% (vol/vol) Triton X-100, 0.1% (wt/vol) SDS,
1mMDTT, protease inhibitormix, and phosphatase inhibitor
cocktails 2 and 3 (Sigma)] for 25min on ice. Lysates were cen-
trifuged at 1,300×g for 10min at 4∘C and supernatants were
collected. Protein concentration was determined by Pierce
BCA protein assay kit (Pierce, Rockford, IL) and equivalent
amounts of each sample were separated onto SDS-PAGE gel
and transferred onto nitrocellulose membranes. Molecular
weights were inferred by comparison to prestained markers
(BioRad, Hercules, CA). Membranes were then blocked in
5% nonfat dry milk in phosphate-buffered saline (PBS) with
0.1% Tween (PBST) for 1 h.The blot was subsequently probed
with a primary antibody to PAR-1 (H-111, 1 : 500, Santa
Cruz Biotechnology, Santa Cruz, CA). After washing the
membrane in PBST, it was incubated with an appropriate
secondary antibody. The membrane was then washed again
in PBST and immunoreactive bands were visualized using
electrochemiluminescence (Amersham Pharmacia Biotech,
Piscataway, NJ, USA).
2.6. ELISA. ELISA for totalMMP-1was performed onneuro-
sphere supernatants using a commercially available kit (R&D
Systems, Minneapolis, MN) according to the manufacturer’s
instructions.
2.7. Flow Cytometry. Animals were euthanized with CO
2
intoxication and immediately perfused with PBS. For each
experiment, two hippocampi from littermates of the same
genotype (WT, 𝑛 = 2; hMMP-1 tg, 𝑛 = 2) were microdis-
sected and combined in a 15mL conical tube filled with
10mL of ice-cold dissection medium (Ca2+ and Mg+ free
HBSS, 0.01% 100mM Sodium Pyruvate, 0.10% Glucose, and
0.01% 1M HEPES) and gently washed 2 times. Dissection
medium was aspirated and tissues were incubated in 5mL
of 0.25% Trypsin in HBSS plus phenol red (Invitrogen) at
37∘C for 10 minutes. Next, 0.5mL of 1% DNase solution
was added to tube and incubated on bench for 3 minutes.
This volume was aspirated and tissue was gently washed 3
times in temperature equilibrated plating medium (MEM
with Earle’s BSS, 10% FBS, 0.45% glucose, 0.01% 100mM
Sodium Pyruvate, 0.01% 200mM Glutamine, and 0.01 Peni-
cillin/Streptomycin). Tissues were then triturated in 2mL
total volumeof platingmedium followed by filtration through
a 70𝜇m pore. Cell suspension was gently centrifuged and
supernatant discarded. Next, cells were resuspended in 4%
paraformaldehyde/PBS for 15min with gentle rotation at
room temperature. After one wash and centrifugation in
PBS, cell membranes were permeabilized in 100% MeOH
for 10min at 4∘C. Cells were washed 3 times in PBS and
incubated overnight in antibody solution (Phycoerythrin
(PE) conjugated anti-SOX2; 656103, BioLegend, San Diego,
CA) made up in PBS-TX at 4∘C. An aliquot of cells was used
as autofluorescence control. Incubations were performed at
4∘C overnight. Flow cytometric analysis was performed with
a BD FACS Aria III machine and FCS express software by De
Novo. For each of the gated populations the percentage and
geometric mean fluorescence intensity (MFI) were analyzed.
2.8. Statistical Analysis. For all experiments using ex vivo
aNPCs data are expressed asmean± SD or SE, as indicated, of
at least three experiments in triplicate. Data were analyzed by
two-tailed, unpaired, Student’s 𝑡-test for comparison of two
groups or ANOVA, followed by Tukey’s post hoc analysis,
for comparison of groups greater than two. Statistical signifi-
cance level was set for 𝑝 values less than or equal to 0.05.
3. Results
3.1. aNPCs from MMP-1 tg Animals Show Increased Prolif-
eration. NPCs were harvested and cultured from wild type
andMMP-1 tg animals. As shown in Figure 1(a), supernatants
from tg cultures express hMMP-1. Cell proliferation was
subsequently observed as a function of time in culture in
WT-derived and tg-derived cells. Interestingly, aNPCs from
tg animals showed enhanced proliferation, when compared
to WT aNPC, at 24, 48, and 72 h time points (Figure 1(b)).
Results shown are mean ± SD from four replicate wells per
genotype and are representative of an experiment performed
with different NPC preparations on three separate occasions
(∗𝑝 < 0.05; ∗∗𝑝 < 0.01). The fold increase from WT control
(0 h) is shown (baseline CPS values were 51,881 ± 10,394 for
WT and 51,422 ± 10,473 for MMP-1 tg). Consistent with
increased proliferation as opposed to survival, as determined
by published techniques [26], cell viability in WT and tg
cultures did not differ (mean percentage ± SD of viable cells:
WT: 88.8 ± 2.3, 𝑛 = 9; MMP-1 tg: 89.2 ± 1.02, Student’s 𝑡-test).
3.2. MMP-1 tg-Derived aNPCs Show Increased Differentiation
towards the Neuronal Lineage. To address the question of
whether NPC differentiation is altered in the background
of enhanced MMP-1 expression, we also performed differ-
entiation experiments on aNPCs from WT and MMP-1 tg
animals. Under appropriate conditions (removal of growth
factors) NPCs express their multipotentiality and give rise
to cells belonging to three neural lineages, namely, neurons,
astrocyte, and oligodendrocyte precursors. Results (mean ±
SD), as shown in Figure 2(a), suggest that differentiation
towards a neuronal lineage is enhanced in the setting of
excess hMMP-1.We indeed observed a statistically significant
increase in the percentage of MAP-2+ cells generated from
hMMP-1 tg-derived compared to WT-derived aNPC (∗∗𝑝 <
0.01, Student’s 𝑡-test). Interestingly, this effect was selective
on the neuronal fate of MMP-1 tg NPC, since the number
of GFAP+ astrocytes was not different in the two genotypes,
while the percentage of NG2+ oligodendrocyte precursors
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Figure 1: aNPCs from MMP-1 tg animals release MMP-1 and have an increased proliferation rate. (a) Supernatants from tg cultures express
hMMP-1 as detected by ELISA. (b) Time course analysis of proliferation for WT and MMP-1 tg-derived aNPC. Cells from tg animals display
an increased proliferation rate, compared to WT-derived aNPC (b). Data are the mean ± SD from four replicate wells and are representative
of an experiment performed with different NPC preparations on three separate occasions (∗𝑝 < 0.05; ∗∗𝑝 < 0.01 versus WT).
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Figure 2: MMP-1 tg-derived aNPCs show increased differentiation towards the neuronal lineage. (a) Differentiation experiments on aNPCs
from WT and MMP-1 tg animals. Data, which represent mean ± SD values, are expressed as percentage over total number of viable cells.
A statistically significant increased percentage of MAP-2+ neurons was generated in vitro by aNPCs from hMMP-1 tg, compared to WT
counterpart. Conversely, the number of cells expressing the oligodendrocyte precursor marker NG2 is significantly reduced in absence of
changes in the number of GFAP+ cells in tg cultures (∗𝑝 < 0.05; ∗∗𝑝 < 0.01 versus WT cells, ANOVA). (b) Representative GFAP, NG2, and
MAP2 immunostaining (in green) in WT and hMMP-1 tg NPC cultures. Nuclei are counterstained by DAPI (in blue).
was significantly reduced in tg-derived cultures compared
to WT-derived cells (∗𝑝 < 0.05, Student’s 𝑡-test). Of note,
there was no genotype effect on the percentage of apoptotic
cells in the variously stained preparations (data not shown).
Representative immunostaining for MAP2, GFAP, and NG2
in WT and hMMP-1 tg cultures is shown in Figure 2(b).
3.3. MMP-1 tg aNPC Associated Changes in Proliferation and
DifferentiationAre PAR-1 Dependent. PAR-1 is aGPCR that is
activated by proteolytic cleavage within N-terminal domain.
The receptor is expressed on neurons and glia in several
brain regions (including hippocampus) [8, 27] and on NPC
in the subventricular zone [28]. To determine whether PAR-
1 is expressed in NPC preparations from murine dentate
gyrus, we performed a Western blot on cell lysates, using
murine hippocampus as a control. As shown in Figure 3(a),
a single predominant band of the expected molecular weight
size (46 kDa) was detected in both samples. To confirm
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Figure 3: MMP-1 tg-associated changes in aNPC proliferation and differentiation are PAR-1 dependent. (a) Western blot analysis for PAR-1
expression in hippocampal (HP) and WT aNPC lysates. A single band at the expected molecular weight (46 kDa) is detected. (b) Effect of
an MMP inhibitor on the proliferation rate of WT and tg cultures. 8 𝜇MMMP inhibitor II (MMPi) significantly reduced aNPC proliferation
in tg cultures at 24 h time point and in both WT and tg cultures at 48 h (∗𝑝 < 0.05; ANOVA) (b). (c) Effect of a PAR-1 antagonist on the
proliferation ofWT and tg cultures. 1 𝜇MBMS-200261 (BMS) reduced proliferation of aNPCs fromMMP-1 tg animal. (d) Effect of the PAR-1
antagonist on the neuronal and nonneuronal differentiation of WT and tg cultures. BMS (1 𝜇M) significantly reduced enhanced neuronal
differentiation and counteracted reduction in NG2+ cells in tg cultures (∗𝑝 < 0.05; ANOVA).
that MMP activity contributes to enhanced proliferation of
tg aNPCs, we tested a broad spectrum inhibitor of MMP
activity (MMP inhibitor II, MMPi, 8𝜇M) for its potential
to inhibit this effect. As shown in Figure 3(b), inhibition
of MMP activity significantly reduced aNPC proliferation
in tg cultures at 24 h time point (∗𝑝 < 0.05; ANOVA)
and significantly reduced proliferation in both WT and tg
cultures at 48 h (∗𝑝 < 0.05; ANOVA). Fold change is
shown (baseline CPS values were 71,863 ± 11,369 for WT and
77,744 ± 7898 for MMP-1 tg). We next examined a PAR-1
antagonist for its potential to inhibit enhanced proliferation
of aNPCs from MMP-1 tg animals. The PAR-1 antagonist
BMS-200261 (BMS), used at 1𝜇Mconcentration, significantly
reduced proliferation of tg-derived aNPCs, and not that of
WT cultures, at 24 h and 48 h time points (Figure 3(c)). Fold
change is again shown (baseline CPS values were 34,496 ±
2,971 forWT and 34,872 ± 3,962 forMMP-1 tg). In parallel, as
shown in Figure 3(d), the same treatment abolished increased
neuronal differentiation in tg-derived aNPC (∗𝑝 < 0.05;
ANOVA). Moreover, BMS counteracted the reduction in
the percentage ofNG2+ oligodendrocyte precursors observed
in tg cultures (Figure 3(d)) (∗𝑝 < 0.05; ANOVA). No signif-
icant effect was elicited by BMS on both neuronal and non-
neuronal populations in WT-derived aNPC (Figure 3(d)). In
addition, cell survival was not affected by the compound
(mean percentage ± SD of viable cells: WT: 94.9 ± 1; WT +
BMS: 95.6 ± 1.2; MMP-1 tg: 95.6 ± 1.4; MMP-1 tg + BMS: 95.9
± 1.6, ANOVA).
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Figure 4:The nuclear translocation of NF-𝜅B is required forMMP-1 tg associated changes in NPC proliferation and differentiation. (a) Effect
of JSH-23 on aNPC proliferation inWT and tg cultures.The drug, tested at 3𝜇M, reduced proliferation of aNPCs in bothWT and tg cultures
at 48 h. (b) Effect of JSH-23 on aNPC differentiation in WT and tg cultures. 3𝜇M JSH did counteract enhanced neuronal differentiation
(∗𝑝 < 0.05; ANOVA) and reduced NG2+ cell number (∗𝑝 < 0.05; ANOVA) in tg cultures, with no effect on WT aNPC.
3.4. The Nuclear Translocation of NF-𝜅B p65 Is Required
for MMP-1 tg Associated Changes in NPC Proliferation and
Neuronal Differentiation. Previous studies have linked PAR-
1 to enhanced NF-𝜅B dependent transcription of genes
including VEGF. Moreover, published studies suggest that
NF-𝜅B signaling is important to AHN [29–31]. We therefore
tested an inhibitor of NF-𝜅B signaling for its effects on NPC
proliferation and differentiation in WT and tg cultures. As
shown in Figure 4(a), the inhibitor of NF-𝜅B p65 nuclear
translocation JSH-23 (JSH, 3 𝜇M) reduced proliferation of
aNPCs in both WT and tg cultures at 48 h. Fold change is
shown (baseline CPS data values were 23,239 ± 532 for WT
and 24,129 ± 4202 forMMP-1 tg). Moreover, JSH significantly
reduced enhanced neuronal differentiation in tg-derived but
not wt-derived cultures (∗𝑝 < 0.05; ANOVA). In parallel,
JSH also counteracted the reduction in the percentage of
oligodendrocyte precursors in tg-derived and not wt-derived
aNPC (Figure 4(b)) (∗𝑝 < 0.05; ANOVA). Of note, JSH did
not have a significant effect on MMP-1 levels in tg cultures
(data not shown) and did not reduce cell survival in WT or
tg cultures (mean percentage ± SD of viable cells: WT: 96.8 ±
0.97; WT + JSH: 96.5 ± 1.24; MMP-1 tg: 95.8 ± 0.7; MMP-1 tg
+ JSH: 95.3 ± 0.9, ANOVA).
3.5. SOX2 Positive NPCs Are Increased in the Hippocampus of
MMP-1 tg Animals. Sequential actions of specific transcrip-
tion factors are critical to proper development of AHN [32].
SOX2 is a transcription factor expressed in undifferentiated
progenitor cells. It is a major mediator of Notch signaling
and it is important to maintenance of the precursor pool in
the adult subgranular zone (SGZ) of the DG [32–34]. We
therefore examined SOX2 positive cell number in WT and
MMP-1 tg hippocampus as a proxy for differences in the size
WT MMP-1 tg
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Figure 5: SOX2 positive NPCs are increased in the hippocampus of
MMP-1 tg animals, compared toWTmice. Flow cytometric analysis
of cell suspensions from murine hippocampus shows that the
percentage of SOX2+ cells is significantly increased in tg compared
to WT mice (𝑛 = 4 hippocampi per group with duplicate samples
run in each of two separate experiments; ∗𝑝 < 0.05, ANOVA).
of this pool. As shown in Figure 5, flow cytometric analysis
of cell suspensions from the hippocampus suggests that the
percentage of SOX2 positive cells is increased in MMP-1 tg
compared to WT mice (𝑛 = 4 hippocampi per group with
duplicate samples run in each of two separate experiments;
∗
𝑝 < 0.05).
4. Discussion
AHN is important to pattern separation and cognitive flex-
ibility [2, 3]. It may also play a role in mood regulation
[35]. Consistent with this possibility, cancer treatments that
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ablate AHN are associated with depression and anxiety [35,
36]. Moreover, AHN is necessary for serotonin reuptake
inhibitors to prevent behavioural correlates of depression in
animal models [37, 38].
MMPs are increasingly recognized as important effectors
of neuronal plasticity in both physiological and pathological
settings [39–43]. In the adult brain, these enzymes are critical
to selected forms of synaptic plasticity and recent work
suggests they may also contribute to AHN. For example,
broad spectrum MMPi reduces proliferation and neuronal
differentiation of neural stem cells from umbilical cord
blood [44], and MMP activity contributes to stroke-induced
neurogenesis [45]. Moreover, MMP-2 expression is detected
in SOX2 immunopositive progenitor cells in the teleost fish,
while siRNA to select MMPs abrogates enhanced neuroge-
nesis in a murine model of intracerebral haemorrhage [46,
47]. Unanswered questions include those related to whether
specific MMPs are sufficient to drive enhanced neurogenesis
and those related to the mechanisms through which MMPs
can enhance aNPC proliferation and/or differentiation.
In the present study, we show that overexpression of
MMP-1 is sufficient to drive increased proliferation of aNPCs
in vitro. Moreover, these data were corroborated by flow
cytometry data demonstrating the presence of a significantly
higher number of SOX2 positive cells in hippocampi of
MMP-1 tg mice when compared to their WT counterpart.
In vitro, MMP-1 overexpression also stimulates enhanced
neuronal fate specification of progenitors, with no changes in
astrocyte generation and a parallel reduction in the number
of NG2+ oligodendrocyte precursors. Importantly, increased
proliferation and enhanced neuronal differentiation ofMMP-
1 tg-derived aNPC could be abrogated by an inhibitor of PAR-
1 signaling. As compared to the broad spectrumMMPi,which
reduced proliferation of both WT and tg aNPCs, a PAR-1
antagonist did not substantially influence this endpoint in
WT cultures. Differential effects of MMP versus PAR antag-
onists could relate to release of murine-encodedMMPs from
tg cultures that act through PAR-1 independent mechanisms
including proneurotrophin conversion [48]. Broad spectrum
inhibition of MMP activity may thus influence neurogenesis
at many levels and differences in both cell proliferation and
survival should be considered.
We also show that an inhibitor of NF-𝜅B p65 nuclear
translocation, JSH-23, reduces neuronal differentiation in a
MMP-1 tg selectivemanner.This is consistent with prior work
in which JSH-23 did not diminish neuronal differentiation
when administered in isolation but did diminish enhanced
neuronal differentiation in response to a drug that could
activate the NF-𝜅B pathway and in parallel increased hip-
pocampal neurogenesis both in vitro and in vivo [31].Though
additional studies will be necessary to determine whether
MMP-1 is a relatively direct effector of NF-𝜅B signaling,
data herein are consistent with the possibility that NF-𝜅B
activation is increased in tg-derived aNPCs.
PAR-1 stimulated effects on aNPC proliferation and dif-
ferentiation are not without precedent. Previous studies with
PAR-1 agonists that may enter the CNS with injury, including
activated protein C (APC) and thrombin [49–51], suggest this
receptor may be important to AHN which follows ischemic
or hemorrhagic insult. APC analogues can also promote
neurogenesis in rodents following focal ischemic stroke [52].
Effects of APC and thrombin on hippocampal neurogenesis
may, however, be most relevant to select pathological states
in which blood brain barrier damage occurs. Moreover,
as compared to thrombin and APC, MMP-1 generates a
unique peptide agonist with the potential to stimulate distinct
intracellular signaling events [12]. Thrombin, APC, and
MMP-1 cleave PAR-1 at arginine 41, arginine 41 or 46, and
aspartate 39, respectively. The MMP-1 generated tethered
ligand is thus longer by at least two amino acids. This is
important in that small differences inGPCR agonist structure
can alter receptor localization, G protein coupling, and the
duration of signaling [53]. Consistent with this, Blackburn
and Brinckerhoff have shown that equimolar concentrations
(5 nM) of MMP-1 and thrombin have differential effects
on human microvessel endothelial cells. MMP-1 stimulates
relatively long-lived increases in p38 andMEK/ERK signaling
and gene expression analysis also showed differences as a
function of agonist [12]. Intriguingly, MMP-1 stimulated a 3-
fold increase in the expression of the proneurogenicmolecule
VEGFA, while there was no increase of VEGFA expression
in response to thrombin [12, 54]. Additional work has linked
PAR-1 signaling to enhanced release of MMP-9 [55], an
additional potential effector of neuronal differentiation [45].
With respect to future studies and the question of the
MMP-1/PAR-1 axis in regulating AHN under physiological
and/or pathological conditions, it should be noted thatMMP-
1 expressionmay be increased in association with select phys-
iological and pathological stimuli relevant to neurogenesis.
Future studies will be necessary to determine whether PAR-
1 activating MMPs are important for neurogenesis in the
background of environmental enrichment and/or antidepres-
sant medication. MMP-1 levels may also be increased in
disorders of the central nervous system characterized by glial
activation. Such disorders include fragile X syndrome [56], a
condition in which enhanced neurogenesis may be observed
[57]. Given that the MMP-1 promoter is driven by transcrip-
tion factors including AP-1, which are strongly modulated
by excitatory neurotransmission [58], future studies might
also address MMP-1 dependent neurogenesis as a function of
seizure activity or electroconvulsive therapy.
5. Conclusions
Herein we suggest that the MMP-1/PAR-1 axis can signif-
icantly impact both the proliferation and differentiation of
aNPCs derived from hippocampus. Additional experiments
may be warranted to determine whether this axis contributes
to neurogenesis-related behaviors including cognitive flexi-
bility and responsiveness to antidepressant therapy. Future
studies might also examine the relevance of this axis to
postinjury neurogenesis.
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